Necrotizing enterocolitis (NEC) has been recognized for well over 5 decades yet remains the most common life-threatening surgical emergency in the newborn. The incidence of NEC has decreased steadily in preterm and very-low-birthweight infants over several decades and is typically uncommon in term newborns and infants with a birthweight greater than 2,500 g. Evidence accumulating during the past decade, however, suggests that practitioners should consider NEC in this broader subset of term infants with chromosomal and congenital anomalies complicated by heart or gastrointestinal defects when signs and symptoms of feeding intolerance, abdominal illness, or sepsis are present. The short- and long-term consequences of NEC are devastating in all infants, and although early disease recognition and treatment are essential, promoting human milk feeding as a primary modality in prevention is critical. This article highlights our current understanding of the pathophysiology, the clinical presentation, the risk factors for NEC in term infants compared with premature infants, and the treatment of NEC and discusses strategies in the prevention of NEC. Finally, we review the long-term consequences of NEC and the importance of primary care practitioners in the long-term care of infants after hospitalization for NEC.
Skip Nav Destination
Article navigation
October 2019
Articles|
October 01 2019
Necrotizing Enterocolitis: Enhancing Awareness for the General Practitioner
Fiona Wertheimer, DO;
Fiona Wertheimer, DO
*Division of Neonatology, Department of Pediatrics, LAC+USC Medical Center, Los Angeles, CA
†Keck School of Medicine, University of Southern California, Los Angeles, CA
Search for other works by this author on:
Roxanne Arcinue, MD;
Roxanne Arcinue, MD
†Keck School of Medicine, University of Southern California, Los Angeles, CA
‡Fetal and Neonatal Institute, Division of Neonatology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA
Search for other works by this author on:
Victoria Niklas, MD, MA
Victoria Niklas, MD, MA
§Prolacta Bioscience Inc, Duarte, CA, and Department of Pediatrics, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA
Search for other works by this author on:
AUTHOR DISCLOSURE
Drs Wertheimer and Arcinue have disclosed no financial relationships relevant to this article. Dr Niklas has disclosed that she is vice president of innovation and medical communication and a shareholder at Prolacta Bioscience Inc. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.
Pediatr Rev (2019) 40 (10): 517–527.
Citation
Fiona Wertheimer, Roxanne Arcinue, Victoria Niklas; Necrotizing Enterocolitis: Enhancing Awareness for the General Practitioner. Pediatr Rev October 2019; 40 (10): 517–527. https://doi.org/10.1542/pir.2017-0338
Download citation file:
Comments